This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2004 Jan;5(1):19-24.

doi: 10.1016/s1535-6108(04)00002-9.

Focus on epithelial ovarian cancer

Robert F Ozols¹, Michael A Bookman, Denise C Connolly, Mary B Daly, Andrew K Godwin, Russell J Schilder, Xiangxi Xu, Thomas C Hamilton

Affiliations

PMID: 14749123
DOI: 10.1016/s1535-6108(04)00002-9

Free article

Focus on epithelial ovarian cancer

Robert F Ozols et al. Cancer Cell. 2004 Jan.

Free article

. 2004 Jan;5(1):19-24.

doi: 10.1016/s1535-6108(04)00002-9.

Authors

Robert F Ozols¹, Michael A Bookman, Denise C Connolly, Mary B Daly, Andrew K Godwin, Russell J Schilder, Xiangxi Xu, Thomas C Hamilton

Affiliation

¹ Fox Chase Cancer Center, Philadelphia, PA 19111, USA. robert.ozols@fccc.edu

PMID: 14749123
DOI: 10.1016/s1535-6108(04)00002-9

No abstract available

PubMed Disclaimer

Similar articles

[Molecular targeted therapies for epithelial ovarian cancer].
Itamochi H, Kigawa J. Itamochi H, et al. Nihon Rinsho. 2012 Jun;70 Suppl 4:622-7. Nihon Rinsho. 2012. PMID: 23156321 Japanese. No abstract available.
Challenges to the paclitaxel/carboplatin algorithm in ovarian cancer treatment.
Zorn KK. Zorn KK. Oncology (Williston Park). 2010 Jul;24(8):738, 740. Oncology (Williston Park). 2010. PMID: 20718253 No abstract available.
An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis.
Chung C, Lee R. Chung C, et al. J Oncol Pharm Pract. 2017 Sep;23(6):454-469. doi: 10.1177/1078155216657165. Epub 2016 Jun 29. J Oncol Pharm Pract. 2017. PMID: 27357817 Review.
The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer.
Gui T, Shen K. Gui T, et al. Cancer Epidemiol. 2012 Oct;36(5):490-6. doi: 10.1016/j.canep.2012.06.005. Epub 2012 Jul 20. Cancer Epidemiol. 2012. PMID: 22818908 Review.
Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
Heo EJ, Cho YJ, Cho WC, Hong JE, Jeon HK, Oh DY, Choi YL, Song SY, Choi JJ, Bae DS, Lee YY, Choi CH, Kim TJ, Park WY, Kim BG, Lee JW. Heo EJ, et al. Cancer Res Treat. 2017 Oct;49(4):915-926. doi: 10.4143/crt.2016.322. Epub 2017 Jan 4. Cancer Res Treat. 2017. PMID: 28052650 Free PMC article.

See all similar articles

Cited by

Integrated analysis of gene expression and tumor nuclear image profiles associated with chemotherapy response in serous ovarian carcinoma.
Liu Y, Sun Y, Broaddus R, Liu J, Sood AK, Shmulevich I, Zhang W. Liu Y, et al. PLoS One. 2012;7(5):e36383. doi: 10.1371/journal.pone.0036383. Epub 2012 May 8. PLoS One. 2012. PMID: 22590536 Free PMC article.
The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer.
Gao J, Yang X, Yin P, Hu W, Liao H, Miao Z, Pan C, Li N. Gao J, et al. Int J Oncol. 2012 Apr;40(4):1203-9. doi: 10.3892/ijo.2011.1293. Epub 2011 Dec 12. Int J Oncol. 2012. PMID: 22159921 Free PMC article.
Antitumor activities of human placenta-derived mesenchymal stem cells expressing endostatin on ovarian cancer.
Zheng L, Zhang D, Chen X, Yang L, Wei Y, Zhao X. Zheng L, et al. PLoS One. 2012;7(7):e39119. doi: 10.1371/journal.pone.0039119. Epub 2012 Jul 24. PLoS One. 2012. PMID: 22911684 Free PMC article.
CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.
Lane D, Matte I, Laplante C, Garde-Granger P, Carignan A, Bessette P, Rancourt C, Piché A. Lane D, et al. Mol Cancer. 2016 Sep 9;15(1):58. doi: 10.1186/s12943-016-0542-2. Mol Cancer. 2016. PMID: 27613122 Free PMC article.
[Comparison of serum cancer antigen 125, human epididymis protein 4, ROMA, and CPH-I for diagnosis of ovarian cancer in Chinese patients with ovarian mass].
Shipeng G, Yongning C, Yadi Z, Chanyuan LI, Qifan J. Shipeng G, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2019 Dec 30;39(12):1393-1401. doi: 10.12122/j.issn.1673-4254.2019.12.02. Nan Fang Yi Ke Da Xue Xue Bao. 2019. PMID: 31907150 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

P50 CA83638/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- Mouse Genome Informatics (MGI)